1. Hojjatzadeh e, Heydari A, Samavat T. The effect of health behvarz’ education level on blood pressure control among hypertensive patients in the rural areas of Qazvin city, Iran %J Journal of School of Public Health and Institute of Public Health Research. 2016;13(4):13-24.
2. Implementation tools, package of essential non-communicable (PEN) disease interventions for primary health care in low-resource settings [Internet]. Organization WH. 2013. Available from: https://www.who.int/ncds/management/pen_tools/en/.
3. Package of essential noncommunicable disease (PEN) interventions for primary health care in low-resource settings. [Internet]. Geneva: World Health Organization. 2010. Available from: http://www.who.int/nmh/publications/essential_ncd_interventions_lr_settings.pdf.
4. Zhang XH, Lisheng L, Campbell NR, Niebylski ML, Nilsson P, Lackland DT. Implementation of World Health Organization Package of Essential Noncommunicable Disease Interventions (WHO PEN) for Primary Health Care in Low-Resource Settings: A Policy Statement From the World Hypertension League. Journal of clinical hypertension (Greenwich, Conn). 2016;18(1):5-6.
5. Upreti SR, Lohani GR, Magtymova A, Dixit LP. Strengthening policy and governance to address the growing burden of diabetes in Nepal. WHO South-East Asia journal of public health. 2016;5(1):40-3.
6. Nyarko KM, Ameme DK, Ocansey D, Commeh E, Markwei MT, Ohene SA. Capacity assessment of selected health care facilities for the pilot implementation of Package for Essential Non-communicable Diseases (PEN) intervention in Ghana. The Pan African medical journal. 2016;25(Suppl 1):16.
7. Mendis S, Al Bashir I, Dissanayake L, Varghese C, Fadhil I, Marhe E, et al. Gaps in capacity in primary care in low-resource settings for implementation of essential noncommunicable disease interventions. International journal of hypertension. 2012;2012:584041.
8. Latt TS, Aye TT, Ko K, Zaw KK. Gaps and challenges to integrating diabetes care in Myanmar. WHO South-East Asia journal of public health. 2016;5(1):48-52.
9. Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Administration and policy in mental health. 2011;38(2):65-76.
10. Peters M, Godfrey C, Khalil H, McInerney P, Parker D, Soares C. Guidance for conducting systematic scoping reviews. International journal of evidence-based healthcare. 2015;13.
11. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology. 2005;8(1):19-32.
12. Sharplin G, Adelson P, Kennedy K, Williams N, Hewlett R, Wood J, et al. Establishing and Sustaining a Culture of Evidence-Based Practice: An Evaluation of Barriers and Facilitators to Implementing the Best Practice Spotlight Organization Program in the Australian Healthcare Context. Healthcare (Basel, Switzerland). 2019;7(4).
13. Baghirov R, Ah-Ching J, Bollars C. Achieving UHC in Samoa through Revitalizing PHC and Reinvigorating the Role of Village Women Groups. Health systems and reform. 2019;5(1):78-82.
14. Bollars C, Naseri T, Thomsen R, Varghese C, Sorensen K, Vries N, et al. Adapting the WHO package of essential noncommunicable disease interventions, Samoa. Bulletin of the World Health Organization.96:578-83.
15. Dorji T, Yangchen P, Dorji C, Nidup T, Zam K. An approach to diabetes prevention and management: The Bhutan experience. WHO South-East Asia journal of public health. 2016;5(1):44-7.
16. Mutale W, Bosomprah S, Shankalala P, Mweemba O, Chilengi R, Kapambwe S, et al. Assessing capacity and readiness to manage NCDs in primary care setting: Gaps and opportunities based on adapted WHO PEN tool in Zambia. PloS one. 2018;13(8):e0200994.
17. Ahir G. Assessment Of Facility-Level Preparedness At Primary And Secondary Health Care Levels For Prevention And Control Of Non-Communicable Diseases: Assessment Of Facility-Level Preparedness For Prevention And Control Of Non-Communicable Diseases. National Journal of Integrated Research in Medicine. 2019;9(6):36-9.
18. Aryal BK, Daud M, Thapa A, Mahotra A, Ale Magar S, Malla CK. Assesssment of Health Facilities for Implementation of Non-communicable Disease Package. Journal of Nepal Health Research Council. 2018;16(2):149-55.
19. Bawazir AA, Al-Surimi K, Suwaidan SD, AlShehri AM, AlFarhan AI, Aboulfotouh MA. Capacity and readiness of primary health care centers for implementation of the basic strategy for prevention and control of non-communicable diseases in Saudi Arabia. A case study from the Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia. Saudi medical journal. 2019;40(6):614-8.
20. Rogers HE, Akiteng AR, Mutungi G, Ettinger AS, Schwartz JI. Capacity of Ugandan public sector health facilities to prevent and control non-communicable diseases: an assessment based upon WHO-PEN standards. BMC health services research. 2018;18(1):606.
21. Collins DRJ, Jobanputra K, Frost T, Muhammed S, Ward A, Shafei AA, et al. Cardiovascular disease risk and prevention amongst Syrian refugees: mixed methods study of Médecins Sans Frontières programme in Jordan. Confl Health. 2017;11:14-.
22. Dweakat R, Barghouthi N, Bouziyeh Y, Abu-Hijleh R, Ramlawi A, Shamasnah I, et al. Clinical audit to assess quality of service in a newly implemented NCD programme: a cross-sectional survey to review a pilot implementation of the WHO PEN approach in Salfit district, occupied Palestinian territory. The Lancet. 2017;390:S28.
23. Khan MA, Walley JD, Khan N, Hicks J, Ahmed M, Khan SE, et al. Effectiveness of an integrated diabetes care package at primary healthcare facilities: a cluster randomised trial in Pakistan. BJGP Open. 2018;2(4):bjgpopen18X101618-bjgpopen18X.
24. Kontsevaya A, Farrington J. Implementation of a package of essential noncommunicable (PEN) disease interventions in Kyrgyzstan: evaluation of effects and costs in Bishkek after one year World Health Organization; 2017 [Available from: http://www.euro.who.int/__data/assets/pdf_file/0011/337844/PEN-Evaluation-ENG-FINAL.pdf?ua=1.
25. Barghouthi N, Dweakat R, Bouziyeh Y, Abu-Hijleh R, Shamasnah I, Ramlawi A, et al. Implementation of WHO package of essential non-communicable disease interventions in the occupied Palestinian territory: assessment of patient perceptions to changes in quality of care with participatory ranking methods. The Lancet. 2017;390:S27.
26. Basu S, Wagner RG, Sewpaul R, Reddy P, Davies J. Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis. The Lancet Global health. 2019;7(2):e270-e80.
27. Collins D, Farrington J, Kontsevaya A, Altymysheva A. Improving the implementation of a package of essential noncommunicable (PEN) disease interventions in Kyrgyzstan: mixed methods service evaluation of pilot health centres: World Health Organization 2017 [Available from: http://www.euro.who.int/__data/assets/pdf_file/0011/355961/PEN-implementation.pdf?ua=1.
28. Dukpa W, Teerawattananon Y, Rattanavipapong W, Srinonprasert V, Tongsri W, Kingkaew P, et Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan. Health policy and planning. 2015;30(8):1032-43.
29. Rattanavipapong W, Luz ACG, Kumluang S, Kusumawardani N, Teerawattananon Y, Indriani CD, et al. One Step Back, Two Steps Forward: An Economic Evaluation of the PEN Program in Indonesia. Health systems and reform. 2016;2(1):84-98.
30. Hyon CS, Nam KY, Sun HC, Garg R, Shrestha SM, Ok KU, et al. Package of essential noncommunicable disease (PEN) interventions in primary health-care settings in the Democratic People's Republic of Korea: A feasibility study. WHO South-East Asia journal of public health. 2017;6(2):69-73.
31. Wangchuk D, Virdi NK, Garg R, Mendis S, Nair N, Wangchuk D, et al. Package of essential noncommunicable disease (PEN) interventions in primary health-care settings of Bhutan: a performance assessment study. WHO South-East Asia journal of public health. 2014;3(2):154-60.
32. Jarvis JD, Woods H, Bali A, Oronsaye E, Persaud N. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists. PloS one. 2019;14(8):e0220781.
33. Martinez RE, Quintana R, Go JJ, Villones MS, Marquez MA. Use of the WHO Package of Essential Noncommunicable Disease Interventions after Typhoon Haiyan. Western Pacific surveillance and response journal : WPSAR. 2015;6 Suppl 1:18-20.
34. Emont SL, Choi WS, Novotny TE, Giovino GA. Clean indoor air legislation, taxation, and smoking behaviour in the United States: an ecological analysis. Tob Control. 1993;2(1):13-7.
35. Rabin BA, Brownson RC, Haire-Joshu D, Kreuter MW, Weaver NL. A glossary for dissemination and implementation research in health. Journal of public health management and practice : JPHMP. 2008;14(2):117-23.
36. Rolleri LA, Fuller TR, Firpo-Triplett R, Lesesne CA, Moore C, Leeks KD. Adaptation Guidance for Evidence-Based Teen Pregnancy and STI/HIV Prevention Curricula: From Development to Practice. American journal of sexuality education. 2014;9(2):135-54.
37. Karsh BT. Beyond usability: designing effective technology implementation systems to promote patient safety. Quality & safety in health care. 2004;13(5):388-94.
38. Dusenbury L, Brannigan R, Falco M, Hansen WB. A review of research on fidelity of implementation: implications for drug abuse prevention in school settings. Health education research. 2003;18(2):237-56.
39. Steckler A, Goodman RM, McLeroy KR, Davis S, Koch G. Measuring the diffusion of innovative health promotion programs. American journal of health promotion : AJHP. 1992;6(3):214-24.